Formulation Development
CureVac´s Optimized mRNA Platform Provides Positive PreClinical Results at Low Dose for COVID-19 Vaccine Candidate
CureVac AG recently announced positive preclinical results at a low dose for its lead vaccine candidate against the novel Coronavirus (SARS-CoV-2). The data showed a…
Almac Discovery Enters Into Licensing Agreement for the Development & Commercialization of ALM301
Almac Discovery, a member of the Almac Group, recently announced an out-licensing partnership with an undisclosed biotechnology company in order to advance the development and…
Cue Biopharma Announces Strategic Research Collaboration
Cue Biopharma, Inc. recently announced it has entered into a research collaboration agreement with Dr. Michael Dustin and the University of Oxford to determine the…
Triphase Accelerator & Catalent Announce Interim Results of a Dose Escalation Phase 1 Clinical Trial
Triphase Accelerator and Catalent recently announced interim results for Triphase Accelerator's multi-center, open-label, monotherapy study of TRPH-222 in heavily pre-treated patients with relapsed and/or refractory…
ChemoCentryx & VFMCRP Announce Topline Data from Phase 2 LUMINA-1 Trial
ChemoCentryx, Inc. and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) recently announced topline data from a 46-patient Phase 2 dose-ranging trial in the orphan kidney…
Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial
Krystal Biotech, Inc. recently announced interim results for a first-in-human Phase 1/2 placebo controlled clinical trial evaluating topical administration of KB105 in patients with autosomal…
MD Anderson & Innovent Biologics Announce Strategic Rare Cancer Development Collaboration
The University of Texas MD Anderson Cancer Center and Innovent Biologics, Inc. recently announced a strategic collaboration agreement to co-develop TYVYT (sintilimab injection), Innovent’s anti-PD-1 monoclonal…
COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs
In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall…..
Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP
Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..
Santhera Signs Agreements in Gene Therapy Research With Rutgers University
Santhera Pharmaceuticals recently announced the signing of two agreements with Rutgers, The State University of New Jersey as part of its program to advance gene…
Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial
Rubius Therapeutics, Inc. recently announced that the first patient has been dosed in its Phase 1/2 clinical trial of RTX-240 for the treatment of patients…
Catalent Partners With Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19
Catalent recently welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab,…
Evelo Biosciences, Rutgers University & Robert Wood Johnson University Hospital Announce Submission of IND for Phase 2 Study of EDP1815 in COVID-19 Patients
Evelo Biosciences, Inc., Rutgers University, and Robert Wood Johnson University Hospital recently announced the submission of an Investigational New Drug (IND) application for an Evelo-sponsored…
AI VIVO Seeks Collaboration Partners to Progress Top-Ranked COVID-19 Therapeutic Candidates
AI VIVO recently announced it is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the company as “top-ranked”…
Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University
Fortress Biotech, Inc. recently announced that Oncogenuity, Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel….
Daré Bioscience & Health Decisions Form Strategic Partnership
Daré Bioscience, Inc. recently announced that the companies have signed a partnership agreement under which Health Decisions will exclusively provide….
Evonik Commissions Advanced Biomaterials Production Facility for Pharmaceutical & Medical Applications
Evonik recently announced the successful commissioning of an advanced biomaterials facility in Birmingham, AL, that will support the increasing global market demand for….
Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….
Proveris Scientific Announces its Laboratory Compliance With cGMP
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced it is expanding its…
Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….
